The University of Pennsylvania

University of Pennsylvania drives new discoveries in cancer immunotherapy research on an international scale, and pioneered the first FDA-approved CAR-T cell therapy. Penn’s award-winning doctors and scientists focus on training immune cells to recognize and hunt cancer cells. PICI at Penn extends this work and supports laboratory studies and clinical trials, recruitment of talented new faculty and opportunities for early-career investigators who will train at Penn.

Carl June, MD | Director
Saar Grill, MBBS, PhD, FRACP | Co-Director
E. John Wherry, PhD | Co-Director